Medical Equipment

Molecular Diagnostics For Sexually Transmitted Diseases Market Revenue Projected To Hit $6.04 Billion By 2030 With 10.4% CAGR

April 16, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Molecular Diagnostics For Sexually Transmitted Diseases Market Between 2026 And 2030? _x000D_

The market size for molecular diagnostics used in sexually transmitted diseases has experienced significant growth recently. It is anticipated to increase from $3.67 billion in 2025 to $4.07 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.7%. The expansion observed in past periods can be linked to factors like the reliance on traditional serological tests, the limited availability of automated PCR systems, a lack of awareness regarding molecular diagnostics in emerging markets, the rising prevalence of sexually transmitted infections, and the labor-intensive nature of manual workflows and testing._x000D_

_x000D_

The molecular diagnostics for sexually transmitted diseases market size is anticipated to undergo significant expansion in the upcoming years, with projections indicating it will reach **$6.05 billion in 2030**, exhibiting a compound annual growth rate (**CAGR**) of **10.4%**. This expected growth during the forecast period is driven by factors such as technological advancements in automated PCR and nucleic acid extraction, the widening availability of point-of-care molecular diagnostics, improvements in healthcare infrastructure within developing regions, the increasing implementation of laboratory information management systems (LIMS), and rising investment in research and development for rapid and multiplexed diagnostic assays. Key developments characterizing this period include the growing adoption of nucleic acid-based testing methods, the expansion of point-of-care molecular diagnostic solutions, a heightened demand for rapid and accurate STD detection, the integration of molecular diagnostics with laboratory information systems, and progress in automated PCR and high-throughput diagnostic platforms._x000D_

_x000D_

#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report_x000D_

_x000D_

What Leading Drivers Are Supporting The Molecular Diagnostics For Sexually Transmitted Diseases Market Expansion?_x000D_

The increasing occurrence of sexually transmitted infections (STIs) is anticipated to drive the expansion of the molecular diagnostics for sexually transmitted diseases market in the future. STIs are defined as infections stemming from bacteria, viruses, or parasites, spread via sexual contact, impacting both the reproductive and urinary systems. The rise in STIs is predominantly attributed to irregular application of protective measures, which contributes to simpler transmission of infections among those who are sexually active. Molecular diagnostics for STIs are crucial in controlling these infections, as they allow for prompt and precise identification of pathogens, even when individuals show no symptoms, thereby aiding immediate treatment, decreasing disease spread, and enhancing overall patient health. For example, data released in June 2024 by the UK Health Security Agency (UKHSA), a UK government body, indicated 401,800 new STI diagnoses in England during 2023. This represented a 4.7% rise from the 383,789 cases documented in 2022. Consequently, the growing prevalence of sexually transmitted infections acts as a significant catalyst for the molecular diagnostics for sexually transmitted diseases market’s growth._x000D_

_x000D_

How Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Categorized Across Its Segment Groups?_x000D_

The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Instruments And Services, Consumables, Software_x000D_

2) By Technology: Laboratory Testing, Point-Of-Care Testing_x000D_

3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services_x000D_

2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers_x000D_

3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software_x000D_

_x000D_

What Emerging Trends Are Seen In The Molecular Diagnostics For Sexually Transmitted Diseases Market?_x000D_

Companies operating within the molecular diagnostics for sexually transmitted diseases market are concentrating on developing advanced solutions, such as rapid point-of-care polymerase chain reaction (PCR) devices, to enhance diagnostic speed, accuracy, and accessibility. These rapid point-of-care PCR devices are portable molecular diagnostic tools that integrate sample preparation, amplification, and detection into a single, compact unit, facilitating timely and highly sensitive pathogen detection outside traditional laboratory settings. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, launched the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device engineered to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without requiring external instrumentation or cold-chain logistics, includes an integrated amplification system, and provides lab-quality results directly at the point of care to support immediate clinical decisions. The test is authorized for prescription home use, making it the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized outside clinical environments. This launch indicates a progression toward decentralized diagnostic solutions that increase availability, particularly for underserved or remote populations._x000D_

_x000D_

Which Firms Are Influencing Competition In The Molecular Diagnostics For Sexually Transmitted Diseases Market?_x000D_

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd. _x000D_

_x000D_

#Get The Full Molecular Diagnostics For Sexually Transmitted Diseases Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report_x000D_

_x000D_

Where Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Primarily Concentrated By Region?_x000D_

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request A Customized Molecular Diagnostics For Sexually Transmitted Diseases Market Report For Competitive Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Molecular Diagnostics For Sexually Transmitted Diseases Market 2026, By The Business Research Company#_x000D_

_x000D_

Trade Credit Insurance Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/trade-credit-insurance-global-market-report_x000D_

_x000D_

Household Insecticides Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report_x000D_

_x000D_

Household Lending Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/household-lending-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_